BP
Insider
Benjamin L Palleiko
CHIEF EXECUTIVE OFFICERBenjamin L Palleiko (CHIEF EXECUTIVE OFFICER) filed 6 Form 4 reports in the trailing twelve months (0 purchases, 6 sales), most often in KALV. The largest single filing was $293K of KALV (10,926 sh × $26.78, as filed), executed May 22. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
6
0 buys · 6 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$870K
shares × price, as filed
Last traded
May 22
Filed May 26
Volume by month
Buys $0
Sells $2.0M
Shares × price, as filed · by filing month · past 24 months
Most traded names
KALV
KALV
0 buys · 12 sells
12 filings
Recent filings
KALVSALE
KalVista Pharmaceuticals, Inc.
View filing →
$517K32,979 sh × $15.69
Exec Jul 9 2025
Filed Jul 10 2025 · 5:30 PM ET KALVSALE KalVista Pharmaceuticals, Inc. View filing → $104K
7,169 sh × $14.50
Exec Jun 9 2025
Filed Jun 10 2025 · 5:30 PM ET KALVSALE KalVista Pharmaceuticals, Inc. View filing → $119K
9,999 sh × $11.88
Exec May 22 2025
Filed May 23 2025 · 5:30 PM ET KALVSALE KalVista Pharmaceuticals, Inc. View filing → $133K
14,400 sh × $9.26
Exec Nov 18 2024
Filed Nov 19 2024 · 5:30 PM ET